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A panel of inﬂuenza virus-like sequences were recently documented in ﬁsh and amphibians.
Of these, the Wuhan spiny eel inﬂuenza virus (WSEIV) was found to phylogenetically cluster
with inﬂuenza B viruses as a sister clade. Inﬂuenza B viruses have been documented to
circulate only in humans, with certain virus isolates found in harbor seals. It is therefore
interesting that a similar virus was potentially found in ﬁsh. Here we characterize the putative
hemagglutinin (HA) and neuraminidase (NA) surface glycoproteins of the WSEIV. Functionally, we show that the WSEIV NA-like protein has sialidase activity comparable to B/
Malaysia/2506/2004 inﬂuenza B virus NA, making it a bona ﬁde neuraminidase that is
sensitive to NA inhibitors. We tested the functionality of the HA by addressing the receptor
speciﬁcity, stability, preferential airway protease cleavage, and fusogenicity. We show highly
speciﬁc binding to monosialic ganglioside 2 (GM2) and fusogenicity at a range of different pH
conditions. In addition, we found limited antigenic conservation of the WSEIV HA and NA
relative to the B/Malaysia/2506/2004 virus HA and NA. In summary, we perform a functional and antigenic characterization of the glycoproteins of WSEIV to assess if it is indeed a
bona ﬁde inﬂuenza virus potentially circulating in ray-ﬁnned ﬁsh.
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nﬂuenza A and B viruses cause widespread infections in
humans on an annual basis resulting in signiﬁcant morbidity
and mortality1. In addition to human infections, inﬂuenza A
virus has been shown to have a broad host tropism, infecting a
variety of different avian and mammalian species2. This enhances
the pandemic potential of these viruses due to an increased
possibility of reassortment in a commonly infected host3. In
contrast, inﬂuenza B viruses have a comparatively limited host
range comprising predominantly of infections in humans.
Sporadic outbreaks have been observed in harbor seals and gray
seals, and this has brought into question the possibility of nonhuman reservoirs for inﬂuenza B viruses4,5. However, sequence
analysis of inﬂuenza B virus isolates from seals suggests that the
causative agents were human strains6. Partial sequences of isolates of inﬂuenza B viruses identiﬁed in swine farms across the
USA displayed high homology to human inﬂuenza B virus isolates as well7. Overall, studies have documented spillage of
inﬂuenza B virus infections from humans to other species,
however, there is limited evidence for the existence of sustained
animal reservoirs for these viruses.
The overall understanding of RNA virus diversity outside of
avian and mammalian species has been limited stemming from
sampling biases towards these hosts8. A study by Shi et al. aimed
at addressing this dearth of sampling in amphibians, ﬁsh, and
reptiles, and identiﬁed 214 vertebrate species-associated virus
sequences through a meta-transcriptomic approach. Most of
these viruses could be categorized into 17 vertebrate-speciﬁc viral
families, signiﬁcantly enhancing the diversity of viral families
historically known to have mammalian or avian hosts. Three
novel inﬂuenza viruses were identiﬁed in ray-ﬁnned ﬁsh (spiny
eel), jawless ﬁsh (hagﬁsh), and amphibians (Asiatic toad). These
were the ﬁrst documented sequences of putative inﬂuenza viruses
in ﬁsh9.
For the Wuhan spiny eel inﬂuenza virus (WSEIV), all eight
genomic segments were recovered following the sampling and
analysis of the transcripts in the gill tissues of lesser spiny eels
(Macrognathus aculeatus). A striking aspect of this virus is its
phylogenetic clustering as a sister clade to inﬂuenza B viruses,
more so than inﬂuenza A viruses do. Alignment of the coding
regions of the eight segments of WSEIV indicates percentage
identity as high as 76% (PB1) and as low as 34% (NS) with
the closest hits all being in the inﬂuenza B virus species. The
surface viral glycoproteins, hemagglutinin (HA), and the neuraminidase (NA) of the WSEIV have a 45% and 48% amino acid
identity to the respective HA and NA of inﬂuenza B viruses9.
Given our interest in studying viral glycoproteins, we decided
to take a deeper dive into characterizing the HA and NA of the
WSEIV and their inﬂuenza B virus counterparts. This could
provide valuable insight into this novel inﬂuenza B-like virus, and
its implication of non-human reservoirs for inﬂuenza B viruses.
Additionally, inﬂuenza B viruses are largely understudied relative
to inﬂuenza A viruses in the context of the functionality and
antigenic landscape, and the ﬁndings from this study contribute
towards addressing this gap10. The questions raised during the
conception of this study were as follows. Does the WSEIV HA
have sialic acid-binding activity and what receptor speciﬁcity does
it possess? Does the WSEIV neuraminidase have sialidase enzymatic activity? How do the functional and antigenic aspects of
these proteins compare to those of inﬂuenza B virus HAs and
NAs and how does this inform the potential of this virus to spill
over into humans?
Here, we demonstrate that the WSEIV HA and NA show
opposing similarity proﬁles relative to inﬂuenza B/Malaysia/2506/
2004 virus HA and NA. The WSEIV HA appears to strongly
interact with a unique gangliosidic receptor, displaying drastically
different target receptor speciﬁcity compared to inﬂuenza B virus
2

HAs. Additionally, we show that the WSEIV HA can be activated
by trypsin, but not any human airway proteases, and it is fusogenic. Taken together, the WSEIV HA interacts with a sialic acidcontaining receptor, can be activated by a protease, and can
mediate fusion. On the contrary, the WSEIV NA, showing sialidase activity, has a notably similar activity proﬁle relative to the
control inﬂuenza B virus NA. Cleavage of the sialic acid residue
on this gangliosidic receptor by the WSEIV NA was also conﬁrmed. Additional functional characterization further reinforces
this dichotomous nature of the HA and NA. Overall, we show
that this WSEIV is indeed a bona ﬁde inﬂuenza virus from a
functional standpoint. We also address the antigenic conservation
of the WSEIV HA and NA using a panel of broadly cross-reactive
monoclonal antibodies (mAbs) and a set of serum samples from
humans positive for the inﬂuenza B virus.
Results
Representative HA and NA amino acid sequences of inﬂuenza A
and B viruses were selected and phylogenetically compared to
the WSEIV HA and NA. Along the lines of the whole virus
genome alignments in the study identifying this virus, we
observed the proximal clustering of the WSEIV HA and NA to
inﬂuenza B virus HAs and NAs (Fig. 1A, E). This encompasses
the seasonal vaccine strains from the two inﬂuenza B virus
antigenic lineages, B/Victoria/2/1987-like and B/Yamagata/16/
1988-like, and the ancestral pre-divergence B/Lee/1940 virus
too11. The sequences of each glycoprotein were superimposed
onto the publicly available structure of inﬂuenza B/Brisbane/60/
2008 virus counterparts to visualize where the ~45% (HA) and
~48% (NA) identity is present (Fig. 1B, F). As a comparative
control, inﬂuenza B/Malaysia/2506/2004 (part of the B/Victoria/
2/1987-like lineage) virus was selected and the HA and NA of this
virus were used for the experiments detailed in this study. These
glycoproteins have previously been expressed in our laboratory at
high yields and purity. We are also equipped with a mousepathogenic B/Malaysia/2506/2004 challenge virus and reverse
genetics system for possible future research avenues to study the
WSEIV HA and NA. A pair-wise alignment of the WSEIV HA
and NA with the inﬂuenza B/Malaysia/2506/2004 virus HA and
NA was carried out (Fig. 1C, G). In the context of the HA, there
appeared to be mismatches in the residues that constitute the
sialic acid interacting receptor binding site12,13. This lack of
conservation was indicative of a potentially altered receptor
binding proﬁle of the WSEIV HA. Additionally, the WSEIV HA
also appeared to have a reduced number of putative N-linked
glycosylation sites as identiﬁed by the consensus sequence N-X(S/T). The reduced glycosylation on the WSEIV HA relative to
the inﬂuenza B/Malaysia/2506/2004 HA was conﬁrmed using a
deglycosylation assay with the respective recombinant proteins. A
larger difference in molecular weight was observed on a reducing
sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS–PAGE) gel for the B/Malaysia/2506/2004 HA pre- and
post-deglycosylation in comparison to the WSEIV HA (Fig. 1D).
From an antigenic standpoint, the target epitope of the paninﬂuenza virus HA mAb, CR9114, was found to have some
mismatches too14. A large number of matched residues, however,
appear to be in the stalk domain of the HA, consistent with
previous studies showing higher levels of conservation in this
region across all inﬂuenza virus HAs15. Signiﬁcant mismatches
were observed in the region immediately upstream to the fusion
peptide, largely conserved, encompassing the proteolytic cleavage
site essential for activation of the HA. The comparison of the NA
sequences, on the other hand, demonstrated a conserved enzymatic active site, as are the regions in its immediate vicinity. A
deglycosylation analysis of the B/Malaysia/2506/2004 and WSEIV
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Fig. 1 Comparative sequence analysis of the WSEIV glycoproteins. Phylogenetic trees based on the amino acid sequences of the WSEIV glycoproteins
and the representative inﬂuenza A and B HAs (A) and NAs (E) obtained from GISAID are shown. The scale bar indicates a 5% difference in amino acid
sequence. Amino acid conservation of the WSEIV HA (B) and WSEIV NA (F) relative to inﬂuenza B virus HA and NA are represented by the residues
highlighted in red. The structure and sequence of inﬂuenza virus strain B/Brisbane/60/2008 were used as a template for comparison. Pairwise alignments
of the WSEIV HA and NA are displayed against inﬂuenza B/Malaysia/2506/2004 virus HA and NA, (C) and (G), respectively. Identical residues are
indicated by asterisks. Functionally and antigenically relevant features have been annotated. Recombinantly expressed HAs (D) and NAs (H) of inﬂuenza
B/Malaysia/2506/2004 virus and WSEIV were visualized on an SDS–PAGE gel in deglycosylated and non-deglycosylated conditions. A representative of
two independent assays is shown. Structures are based on PDB# 4FQM50 for HA and PDB# 4CPL51 for NA.

NA did not reveal any overt differences in glycosylation patterns
across the glycoproteins with comparable shifts in molecular
weights pre- and post-deglycosylation (Fig. 1H).
The WSEIV HA and NA were studied and characterized in the
form of recombinant proteins as opposed to in a viral backbone
for several reasons. The available sequences for these proteins

comprised only the coding regions from the study identifying
them. Consequently, the packaging sequences in the non-coding
regions essential to rescuing these glycoproteins in an inﬂuenza B
virus backbone were not available. More importantly, introducing
novel glycoproteins into a known human pathogen, e.g. a humanadapted inﬂuenza B virus backbone possesses a biosafety risk. As
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a result, these proteins were studied in a recombinant form to
ensure to meet safety concerns. The B/Malaysia/2506/2004 and
WSEIV HAs and NAs were expressed using a baculovirus
expression system as previously described16. Since the available
sequence for the WSEIV HA consisted of a truncated signal
sequence, a full-length signal peptide from the B/Malaysia/2506/
2004 virus HA was added instead. A C-terminal T4 trimerization
domain was used to ensure the expression of the HAs in their
native trimeric state. An N-terminal vasodilator stimulating
phosphoprotein (VASP) tetramerization domain was used to
maintain tetrameric structures of the respective neuraminidases.
To determine whether the WSEIV HA is capable of hemagglutinating erythrocytes, a conventional hemagglutination assay
was carried out. Recombinant WSEIV and B/Malaysia/2506/2004
HA were incubated with 0.5% chicken and turkey erythrocytes
starting at a concentration of 10 µg of recombinant HA. The B/
Malaysia/2506/2004 HA caused hemagglutination of both
chicken and turkey RBCs while an absence of hemagglutination
was observed with the WSEIV HA at the same concentrations
(Fig. 2A). Although this has been observed for recent H3N2 virus
isolates, we were intrigued by the lack of hemagglutination and
questioned the receptor usage of the WSEIV HA17. The receptor
binding speciﬁcity of the hemagglutinin protein of inﬂuenza
viruses is a vital parameter in addressing the potential of these
viruses to cross species barriers and determining host and tissue
tropism for infection18. Glycan arrays are an instrumental tool in
identifying the target receptor speciﬁcity for inﬂuenza virus HAs
in determining whether they preferentially bind to α2,3-linked or
α2,6-linked sialic acid receptors. We took advantage of this
approach to further interrogate interactions between WSEIV HA
and its potential binding partners. As a control, the recombinant
H5 HA from A/Vietnam/1203/2004 H5N1 inﬂuenza A virus,
inﬂuenza B/Malaysia/2506/2004 virus rHA, and the WSEIV rHA
were applied to a glycan array comprising of a variety of asialo,
α2,3-linked, α2,6-linked and gangliosidic structures (Fig. 2B). All
recombinant HAs were probed with a ﬂuorescently tagged antihexahistidine antibody to determine the extent of binding to
different glycans present on the array. In line with previously
published receptor speciﬁcity proﬁles for avian HAs, the H5 rHA
preferentially and predominantly binds to α2,3-linked sialic acids
present on the array19. The rHA of inﬂuenza B/Malaysia/2506/
2004 virus shows binding to both α2,3-linked and α2,6-linked
sialic acids, which has previously been attributed to the presence
of a Phe95 residue in inﬂuenza B virus HA as opposed to a
conserved tyrosine residue at the same site in inﬂuenza A
viruses20,21. The WSEIV HA showed a unique binding proﬁle on
the glycan array (Fig. 2B), no binding was observed to α2,3-linked
or α2,6-linked sialic acids of increasing length as seen for the
inﬂuenza B virus HA. Strong ﬂuorescence intensity indicative of
binding was observed on a singular spot on the array corresponding to a ganglioside oligosaccharide, GM2. This monosialylated ganglioside has an α2,3-linked sialic acid at the
penultimate galactose residue. To validate this interaction of the
WSEIV HA and GM2, bio-layer interferometry was applied to
determine a dissociation constant (Kd) and thereby binding afﬁnity (Fig. 2C). To do so, Ni-nitriloacetic acid (Ni-NTA) sensors
were loaded with ﬁxed concentrations of hexahistidine-tagged
rHA proteins (10 µg/ml) and dipped in 1.5× fold serial dilutions
of recombinant GM2 starting at 100 µM. After ensuring that the
sensors were loaded to saturation with the hexahistidine-tagged
HAs, the association and dissociation kinetics of the HA–GM2
interaction were studied. An A/ﬂat-faced bat/Peru/033/10 H18
hemagglutinin was applied as a negative control given its
unconventional nature to interact with MHC class II as receptors
for entry as opposed to sialic acid residues22. No binding
was observed for the H18 rHA and as observed previously in the
4

glycan array, B/Malaysia/2506/2004 rHA also showed no binding
to GM2. The WSEIV HA on the other hand shows excellent
association and dissociation proﬁles in a biphasic fashion with
GM2 in a dose-dependent manner. Analysis of this binding
allowed us to determine the Kd value of this interaction at
7.36 × 10−7 M, in the micromolar range, with R2 and χ2 indicating good curve ﬁts. These ﬁndings indicate and validate that
the GM2 ganglioside is a target receptor for this WSEIV HA.
Evidently, the WSEIV HA has a contrasting sialic acid-binding
proﬁle in comparison to the inﬂuenza B virus rHA control.
Typically, following the receptor interaction of the HA with
sialic acid, the HA mediates membrane fusion of the inﬂuenza
virion allowing for the subsequent steps of infection and replication to occur. However, this requires the HA to be fusion
competent, a state that is reliant on host cell protease-mediated
activation. Cleavage by host proteases at the target site on the HA
upstream of the fusion peptide splits the HA0 precursor into the
HA1 and HA2 polypeptides23. Recently, a study dissected the
difference in preferential proteolytic cleavage of inﬂuenza A and
inﬂuenza B virus HAs by human airway proteases24. This is
crucial in addressing host adaptation of HAs and instrumental in
the crossing of species barriers with relative ease as observed with
highly pathogenic avian inﬂuenza viruses containing a polybasic
cleavage site, resulting in easier cleavage and priming of the HA
by furin-like proteases25. Inﬂuenza B virus HAs have been found
to be cleaved by a broad range of human airway proteases
belonging to the type II transmembrane serine protease and
kallikrein protease families24. We assessed the extent to which
these proteases can cleave the WSEIV HA (Fig. 2D). Human
embryonic kidney (HEK) 293T cells were co-transfected with
pCAGGS expression plasmids encoding for either the WSEIV or
the B/Malaysia/2506/2004 HA and pcDNA expression plasmids
encoding individual human airway proteases. The proteases
selected here have been previously shown to cleave inﬂuenza B
virus HAs24. As an untreated control, HEK293T cells were
transfected only with pCAGGS expression plasmids encoding
the respective HAs. N-tosyl-L-phenylalanine chloromethyl ketone
(TPCK)-treated trypsin was used as an additional control, with
pCAGGS HA-transfected cells being incubated with exogenous
trypsin brieﬂy prior to harvesting of the cells. Cleavage of HA0
was detected through Western blotting after running the transfected cell lysate on a reducing sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) gel. A
pool of monoclonal antibodies that are broadly cross-reactive to
inﬂuenza B virus HAs and polyclonal sera raised against the
WSEIV rHA in mice were used to detect cleavage of the B/
Malaysia/2506/2004 HA and WSEIV HA, respectively. Proteolytic cleavage of the B/Malaysia/2506/2004 HA was detected to
varying extents with this panel of human airway proteases, evidenced by the presence of the HA1 bands (~50 kDA) in addition
to the HA0 bands (75 kDA). Strikingly, none of the selected
human airway proteases were able to cleave and activate the
WSEIV HA. HA1 was detectable only in the trypsin treated
sample (Fig. 2D). To determine whether the WSEIV HA is
fusogenic, a polykaryon formation assay was performed at different pH conditions. HeLa cells were transfected with pCAGGS
expressing the WSEIV HA. Following trypsin treatment to activate the HAs expressed on the cell surface, the cells were exposed
to different pH conditions and incubated for 4 h to allow fusion
to occur. Visualization of the cells at different pH conditions
showed the presence of polykaryons at a variety of different pHs
tested from pH 4.5 to 5.9 (Fig. 2E). No polykaryons were formed
at a control pH of 7.4 or in untransfected cells. Overall, this result
supports the notion that the WSEIV HA is functionally divergent
from the inﬂuenza B virus HA. The WSEIV HA interacts with a
unique GM2 gangliosidic receptor, is not activated by human
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airway proteases, and is fusogenic at a wide range of pH
conditions.
Given that the primary active site residues crucial for the sialidase activity of the NA are conserved, we tested the functional
activity of the WSEIV NA. To do so, a conventional enzymelinked lectin assay (ELLA) was carried out using fetuin as a
substrate (Fig. 3A). Recombinant NAs were applied in 3-fold
serial dilutions starting at 15 µg/ml and the extent of NA activity
was determined based on the extent of sialic acid cleavage,
detected by binding of peanut agglutinin lectin to exposed
galactose residues. The overnight incubation of the rNA with
fetuin was carried out at four different temperatures, 4, 20, 33,
and 37 °C to determine the temperature dependence of the NA
activity. These were selected to encompass the possible

ARTICLE

temperatures encountered by the spiny eels in their freshwater
environment in the Wuhan area. Given that the enzymatic
activity of the inﬂuenza B NA is understudied, an N9 rNA from
the A/Anhui/1/2013 H7N9 virus was used as a comparative
control. The major observation was that the WSEIV NA does
indeed have neuraminidase activity (Fig. 3A). This enzymatic
activity is also starkly similar to that of the B/Malaysia/2506/2004
NA at the tested temperatures. Preliminary analysis suggests that
the N9 rNA appears to have higher enzymatic activity compared
to both the inﬂuenza B virus and inﬂuenza B virus-like NAs. To
better understand the temperature dependency, the speciﬁc
activity of the NA was determined using the inverse of the halfmaximum lectin binding. As expected, we observe a step-wise
reduction in the activity of each NA at lower temperatures. The
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Fig. 2 The WSEIV HA has a divergent functional proﬁle relative to the inﬂuenza B/Malaysia/2506/2004 virus HA. A Recombinant HA proteins
starting at 10 µg serially diluted two-fold were applied in a classical hemagglutination assay with 0.5% chicken or turkey erythrocytes. B Receptor binding
speciﬁcity of the WSEIV HA was determined using a glycan microarray. A/Vietnam/1204/2004 H5 and B/Malaysia/2506/2004 HAs served as controls
to compare binding proﬁles of the HAs. Glycans 1-4 represent asialic structures with the indicated backbones. Glycans 5-8 and 9-12 are α2,3- and α2,6linked sialic acid glycans, with A–L comprising complex glycans and gangliosides. A simpliﬁed structure of the GM2 ganglioside, sample B on the array is
shown. The mean signal for each glycan–HA binding is shown with each glycan printed in replicates of 6. Error bars indicate standard deviation and
technical replicates were performed. The binding was conﬁrmed with two separate batches of recombinant WSEIV HA. C The WSEIV HA–GM2
ganglioside interaction was validated by bio-layer interferometry. B/Malaysia/2506/2004 HA and H18 HA were used as negative controls with expected
absence of binding towards GM2. The association and dissociation kinetics curve ﬁts of the interaction are shown and the dissociation constant (Kd) was
calculated accordingly. D Western blotting was performed to determine the proteolytic cleavage proﬁle of the WSEIV and B/Malaysia/2506/2004 HAs
by human airway proteases. Cell lysate was generated following co-transfection with pCAGGS HAs and pcDNA3.1 protease expressing plasmids. HA1 was
detected as a marker for proteolytic cleavage alongside uncleaved HA0. Cells transfected with pCAGGS HA either untreated or exposed to TPCK-treated
trypsin served as controls for proteolytic cleavage. Representative images of two independent assays are shown. E A polykaryon formation assay was
applied to determine the fusogenicity of the WSEIV HA. HeLa cells transfected with the pCAGGS WSEIV HA were treated with TPCK-treated trypsin,
exposed to different indicated pH conditions, and allowed to recover to determine for cell-to-cell fusion. This assay was performed in independent
duplicates and a representative image is shown.

speciﬁc activity proﬁle is also almost identical for the WSEIV NA
and the B/Malaysia/2506/2004 NA.
Keeping in mind the novel aspect of the WSEIV NA recently
identiﬁed in a non-human host, we investigated its potential
sensitivity to the NA inhibitor such as oseltamivir (Tamiﬂu),
peramivir or zanamivir (Fig. 3B). This was tested using a neuraminidase inhibition ELLA assay wherein ﬁxed concentrations of
rNAs were pre-incubated with oseltamivir starting at 156.28 µM
and serially diluted two-fold prior to being transferred onto fetuin
coated plates. The extent of inhibition was estimated by increased
lectin binding with lower oseltamivir concentrations. The WSEIV
NA was sensitive to oseltamivir, and the dose dependency was
identical for all the tested recombinant NAs (Fig. 3B). Similar
results were obtained with peramivir and zanamivir although
these drugs showed higher potency than oseltamivir. These
ﬁndings also align with the aforementioned observation that the
active site of the WSEIV NA and the surrounding regions are well
conserved to the B/Malaysia/2506/2004 NA allowing for the
binding and inhibition by NA inhibitors.
To follow up on the unique receptor binding proﬁle shown by
the WSEIV HA, we questioned whether the WSEIV NA has
altered substrate speciﬁcity compared to the B/Malaysia/2506/
2004 NA (Fig. 3C). To probe this, ELLAs were carried out as
previously described in a study looking at N9 NA in H7N9
inﬂuenza A viruses26. Lectins with different binding speciﬁcities
were used to determine if the NAs preferentially cleaved α2,3linked or α2,6-linked sialic acids using fetuin as a substrate which
carries both these linkages in a 2:1 ratio27. Speciﬁcally, Erythrina
crista-galli (ECA), peanut agglutinin (PNA), Maackia amurensis
lectin I (MALI), and Sambucus nigra lectin (SNA) were used.
ECA and PNA both have been found to show binding to nonsiaylated N- and O-linked sugars respectively, hence their binding
would be higher in the presence of a NA28,29. MALI and SNA
preferentially bind only α2,3- and α2,6-linked sialic acids,
respectively, and their binding decreases with NA cleavage of the
target substrates30,31. As described earlier, the speciﬁc activity of
the NA was determined and normalized to that seen with fetuinECA for each NA. In line with the enzymatic activity, the WSEIV
and B/Malaysia/2506/2004 NA have equivalent substrate speciﬁcities, with both having comparable cleavage proﬁles (Fig. 3C).
Although a similar conclusion can be drawn for the A/Anhui/1/
2013 N9 neuraminidase, this preferential cleavage appears to be
more polarized. Subsequently, we characterized the kinetics of the
enzymatic reactions of these NAs, i.e. do these NAs have comparable enzyme kinetics despite having similar temperaturedependent activity and substrate speciﬁcity? To investigate this,
we derived the Michaelis–Menten parameters, Vmax and Km, from
6

the NA–sialic acid enzyme–substrate reaction (Fig. 3D). At a
ﬁxed concentration, rNAs were incubated with the ﬂuorogenic 4methylumbelli-feryl N-acetyl-α-D-neuraminic acid (MUNANA)
substrate and the relative ﬂuorescence readings were taken every
90 s for 40 min as previously described32. The velocity of the
reactions were determined for each concentration of MUNANA
(starting at 1000 µM) and accordingly the Vmax and Km were
calculated. The maximum enzymatic activity, Vmax, for both the
WSEIV and B/Malaysia/2506/2004 NA are similar to each other,
and they both display a high afﬁnity for the MUNANA substrate
(indicated by the 1/Km). The N9 rNA shows exponentially higher
maximum enzymatic activity and a markedly lower afﬁnity for
the substrate, which could possibly explain the stronger speciﬁc
activity seen earlier while measuring substrate afﬁnity.
The neuraminidase plays a crucial role in the viral life cycle in
the context of facilitating viral egress and release through the
cleavage of sialic acid bound to the viral HA. This allows for
productive infection cycles in the host. In context of WSEIV, this
would require the NA-mediated cleavage of the α2,3-linked sialic
acid residue on the cognate GM2 receptor of the WSEIV HA. To
determine whether the WSEIV NA possesses this ability, a free
sialic acid assay and a thin layer chromatography-based approach
were used in parallel. Recombinant GM2 was incubated with the
WSEIV NA and the free sialic acid content was evaluated using a
commercially available kit. As a negative control, GM2 was
incubated with an irrelevant protein (bovine serum albumin).
Fetuin incubated with WSEIV NA was used as a positive control.
Cleavage of the sialic acid on GM2 was observed as determined
by the presence of free sialic acid (Fig. 3E). This was also visualized following thin-layer chromatography wherein GM2 incubated with WSEIV NA ran further on the chromatogram in
comparison to untreated GM2 or GM2 treated with BSA
(Fig. 3F). Fetuin incubated with WSEIV NA was not visualized on
this chromatogram given the higher molecular weight of fetuin
compared to GM2, and hence the lack of migration following
sample spotting.
Having characterized the functionality of the WSEIV HA and
NA, we focused on surveying the extent to which broadly crossreactive epitopes identiﬁed on inﬂuenza B virus HAs are conserved on these glycoproteins (Fig. 4A, B). Probing of the WSEIV
HA and NA was carried out using a panel of broadly crossreactive human and mouse monoclonal antibodies (mAbs) previously characterized to bind to both antigenic divergent and
ancestral lineages of inﬂuenza B viruses14,33–37. Control enzymelinked immunosorbent assays (ELISAs) were performed for these
mAbs against the inﬂuenza B/Malaysia/2506/2004 virus HA and
NA and robust binding proﬁles for most of the tested antibodies

NATURE COMMUNICATIONS | (2021)12:6161 | https://doi.org/10.1038/s41467-021-26409-2 | www.nature.com/naturecommunications

NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-26409-2

were observed. Five antibodies showed strong binding to the
WSEIV HA, namely, 1B5, 4C10, 8G3, 9B9, and 11C12 (all murine
mAbs, Fig. 4A). With the exception of 1B5, all these mAbs bind
to linear epitopes on the conserved long alpha helix in the stalk
domain of the inﬂuenza B virus HA33. As stated earlier, conservation between the WSEIV and B/Malaysia/2506/2004 HA (or
inﬂuenza B virus HAs at large) is relatively high in this region

ARTICLE

(Fig. 1B, C). No binding of the pan-inﬂuenza virus HA human
mAb CR9114 was detectable, as anticipated from the mismatches
in the binding epitope of the antibody14. The binding of CR9114
to inﬂuenza B virus HA was low but detectable. Of the panel of
human and mouse mAbs used to probe the WSEIV NA, only one
antibody showed detectable and strong binding (Fig. 4B). This
human mAb, 1G01, has been characterized to have a target
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Fig. 3 Functionally, the WSEIV NA is strikingly similar to the inﬂuenza B/Malaysia/2506/2004 virus NA. A Sialidase activity of recombinant WSEIV,
inﬂuenza B/Malaysia/2506/2004 and A/Anhui/1/2013 H7N9 NA proteins was evaluated in an enzyme-linked lectin assay using fetuin, at four
temperatures; 4, 20, 33, 37 °C. The curves indicate absorbance measured at 490 nm with error bars indicating standard deviation. Speciﬁc enzyme activity
(inverse of half-maximum lectin binding) determined by these absorbance curves are shown for each individual NA at each temperature. B Susceptibility to
NA inhibitors was tested in an ELLA-based neuraminidase inhibition assay . Error bars indicate standard deviation. Absorbance at 490 nm based on lectin
binding was measured with increasing concentrations of oseltamivir, peramivir or zanamivir. C Neuraminidase substrate speciﬁcity was assessed using an
ELLA with fetuin and lectins with different speciﬁcities (ECA, PNA, SNA, and MALI). Speciﬁc enzyme activity was determined as described in (A) and it is
represented as a percentage normalized to fetuin-ECA. D Michaelis–Menten parameters, Vmax and Km, were estimated based on enzymatic activity of
recombinant NAs against MUNANA substrate. The A/Anhui/1/2013 N9 NA served as a comparative control for both the WSEIV and B/Malaysia/2506/
2004 NAs. E Cleavage of sialic acid on GM2 by the WSEIV NA was conﬁrmed using an assay to measure free sialic acid content (sialic acid NANA assay
kit, Abcam). F Thin layer chromatography was used to visualize the presence of cleaved GM2 following treatment with the WSEIV NA. The arrow shows
the direction in which the chromatography was run. A representative image is shown after the assay was performed in independent duplicates. Technical
duplicates were performed once for (A–E).

binding epitope in the active site of the NA facilitated by a long
heavy chain CDR3 loop. Consequently, the breadth of the antibody encompasses inﬂuenza A and B virus NAs, showing neuraminidase inhibition activity against most of the tested inﬂuenza
virus NAs35. Overall, we observe an interesting proﬁle for the
WSEIV HA and NA from an antigenic standpoint. For a functionally dissimilar WSEIV HA, there are a larger number of
conserved epitopes distributed in the stalk domain. Conversely,
identical functionality seen for the WSEIV NA with B/Malaysia/
2506/2004 NA is accompanied by an absence of this conservation
outside of the enzymatic active site pocket (Fig. 1E, F). Additionally, serum samples from humans post-seasonal inﬂuenza
vaccination (collected between 2017 and 2019) were used in
ELISAs against the WSEIV HA and NA (Fig. 4C). This was done
to identify basal or pre-existing cross-reactive immunity against
the WSEIV HA or NA in humans as a consequence of seasonal
vaccination or prior inﬂuenza virus infection. Safely assuming
immunological naivety, a recombinant glycoprotein from Mopeia
virus, belonging to the arenavirus family, was used as a target
antigen in ELISAs to establish baseline reactivity in our assay. No
pre-existing immunity or post-vaccination-induced antibodies
were detected against the WSEIV HA or NA further reinforcing
the limited conservation of broadly cross-reactive target epitopes
as determined by the panel of mAbs earlier.
Discussion
Here, we have characterized the putative HA and NA of the Wuhan
spiny eel inﬂuenza virus, an inﬂuenza B-like virus identiﬁed via
sequence analysis in lesser spiny eels. The two studies that identiﬁed
the WSEIV and a salamander inﬂuenza-like virus that also clusters
close to inﬂuenza B viruses discuss the occurrence of prolonged
virus–host co-divergence with several host-switching events over
time9,38. Largely, inﬂuenza B viruses have been discounted from
being a pandemic threat due to the absence of an identiﬁed sustained
non-human reservoir. Co-circulating inﬂuenza B viruses in humans
have been shown to have reassortment potential within the two
antigenic lineages, with B/Victoria/2/87-like viruses acquiring gene
segments from B/Yamagata/16/88-like viruses39. Taken together, this
strengthens the unmet need for studies characterizing novel inﬂuenza
B-like viruses in undersampled hosts and subsequently understanding the functionalities of these understudied viruses. Considering that vaccine approaches towards inﬂuenza viruses predominantly
target the dominant HA - and more recently the NA - surface glycoproteins, it is vital to have a comprehensive understanding of these
proteins of inﬂuenza B-like viruses too40. In addition, our characterization of the B/Malaysia/2506/2004 HA and NA also supplements existing literature on inﬂuenza B virus glycoproteins which is
ﬁnite in contrast to studies addressing inﬂuenza A viruses.
Along with showing limited antigenic conservation, we demonstrate that the WSEIV HA interacts with an a-series ganglioside,
8

GM2, as a target receptor. Although GM2 has been identiﬁed as an
interacting partner for some reoviruses and rotaviruses, it has been
shown to be not recognized by inﬂuenza A viruses, with studies
demonstrating that gangliosides are entirely non-essential for inﬂuenza virus entry41–44. As a therapeutic target, overaccumulation of
GM2 on neuronal cells has been implicated in Tay Sachs and
Sandhoff diseases with mutations rendering hexosaminidases nonfunctional45. GM2 overexpression is also observed in a variety of
human cancers and has been linked with increased tumor angiogenesis and metastatic potential46,47. The WSEIV HA also appears
not to bind to GM1a or GM3 as observed from the glycan array
binding analysis. The receptor binding also seems to rely on the
terminal GalNAc residue given that the loss of this in GM3 is
accompanied by abrogation in binding. The location of the α 2,3linked sialic acid residue in GM2 appears to be crucial as no binding
is seen to a galactose extended GM1a ganglioside. From the perspective of gene therapy, having a viral glycoprotein that selectively
targets this ganglioside could prove to be instrumental when pseudotyped into viral vectors for gene delivery. In an aquatic setting,
GM2 has been found to be over-expressed in gills, brain, heart, and
reproductive organs of ﬁsh (zebraﬁsh) corroborating the discovery of
the WSEIV in the gills of lesser spiny eels48. For the WSEIV NA, our
ﬁndings highlight the strong conservation of enzymatic activity and
kinetics, substrate speciﬁcity, and neuraminidase inhibitor sensitivity
with the corresponding inﬂuenza B virus NAs. Especially the similar
temperature proﬁles of WSEIV and inﬂuenza B virus NAs are
interesting since the expectation was that the WSEIV NA would be
more active at lower temperatures as found in the habitat of the lesser
spiny eel. This also raises the possibility that the WSEIV is actually of
mammalian or avian origin. Additional studies are needed to further
determine if the virus is a bona ﬁde ﬁsh virus or if it originated from
other, warm-blooded animals.
The abundant expression of GM2 across different organs in zebraﬁsh supports the possibility that the WSEIV could infect other
species of ﬁsh as well. Consequently, human infection could occur
with individuals directly interacting with these aquatic species at, e.g.
at commercial ﬁsheries or aquaria as well as during recreational
ﬁshing or swimming. The lesser spiny eel (M. aculeatus) and other
Macrognathus species are distributed throughout Southeast Asia and
are farmed and harvested for food49. Of note, GM2 is of course also
present in humans. In addition, we found very limited antigenic
similarity between WSEIV and inﬂuenza B virus glycoproteins.
Cross-reactivity of mAbs was limited to a small subset of antibodies
and no cross-reactivity was found in human serum suggesting that
humans are immunologically naïve to the WSEIV glycoproteins.
In summary, the WSEIV HA and NA proteins show varying
degrees of similarity to their inﬂuenza B virus counterparts. The
HA displays sialic acid binding activity speciﬁcally towards GM2
and thereby differs substantially from known inﬂuenza A and B
virus HAs, and the NA is indeed a sialidase with very similar

NATURE COMMUNICATIONS | (2021)12:6161 | https://doi.org/10.1038/s41467-021-26409-2 | www.nature.com/naturecommunications

NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-26409-2

ARTICLE

Fig. 4 Epitopes that are broadly conserved in inﬂuenza B virus glycoproteins are largely absent the WSEIV HA and NA, with cross-reactivity
being mostly restricted to the stalk domain of the HA and active site of the NA. A and B Binding proﬁles of broadly cross-reactive anti-inﬂuenza B virus
HA and NA human (H) and mouse (M) monoclonal antibodies in ELISAs are shown against recombinant B/Malaysia/2506/2004 and WSEIV HA and
NAs. 4F11 (anti-inﬂuenza B virus NA) and 4C2 (anti-inﬂuenza B virus HA) mouse mAbs were used as negative controls for the ELISAs against the HAs and
NAs respectively. C Presence of pre-existing immunity or induction of cross-reactive antibodies against the WSEIV HA and NA was evaluated through
ELISAs using human serum samples obtained post-seasonal inﬂuenza vaccination (n = 18). Mopeia virus glycoprotein was used as a negative control for
baseline establishment, and area under the curve was calculated with a cutoff of average plus three times the standard deviation of the blank wells. The
geometric mean for each group is indicated with a line. Experiments were performed once in technical duplicates.

functionality compared to inﬂuenza B virus NA. The data provided in this study contribute to our overall understanding of
inﬂuenza B and inﬂuenza B-like viruses, and to understanding of
the pandemic potential of the inﬂuenza B-like viruses from nonhuman reservoirs.
Methods
Cells and proteins. Human embryo kidney 293T cells were cultured in complete
Dulbecco’s modiﬁed Eagle medium (DMEM; Life Technologies) constituted by
DMEM supplemented with Pen-Strep antibiotics (100 U/ml penicillin, 100 µg/ml
streptomycin; Gibco), 10% fetal bovine serum (FBS, HyClone), and 10 ml of 1 M 4(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, Life Technologies).

Sf9cells (ATCC CRL-1711) and High Five cells (BTI-TN-5B1-4 subclone; Vienna
Institute of Biotechnology) were grown in Trichoplusia ni medium-formulation
Hink (TNM-FH) insect medium (Gemini Bioproducts) supplemented with PenStrep and 10% FBS, and serum free medium (SFM) insect cell medium (HyClone),
respectively33.
The recombinant proteins used in this study (WSEIV HA, WSEIV NA, B/
Malaysia/2506/2004 HA, B/Malaysia/2506/2004 NA, A/Vietnam/1203/2004 H5
HA, A/ﬂat-faced bat/Peru/033/2010 H18 HA, A/Anhui/1/2013 N9 NA) were
expressed and puriﬁed from High Five cell culture supernatant as described in
detail previously16.
Phylogenetic and comparative sequence analysis. Phylogenetic trees for the HA
and NA were generated as described previously33. Brieﬂy, sequences were obtained
from the Global Initiative on Sharing All Inﬂuenza Data (GISAID), aligned using
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Clustal Omega (v1.2.4), and the phylogenetic trees were generated using FigTree
(v1.4.3). The annotation of the tree was carried out in Adobe Illustrator CS5.1.
Pairwise alignment of the WSEIV HA and NA (MG600041.1 and MG600042.1)
and B/Malaysia/2506/2004 HA and NA (CY040449.1 and CY040451.1) was performed using Clustal Omega v1.2.4, following which the features of note were
labeled in Adobe Illustrator CS5.1. For the rendered model of glycoproteins displaying sequence conservations, the WSEIV HA and NA were aligned pairwise
against the B/Brisbane/60/2008 HA and NA. The alignment was superimposed on
the B/Brisbane/60/2008 HA and NA structures publicly available on PDB (HA:
4FQM50; NA: 4CPL51) using UCSF Chimera.
SDS–PAGE and Western blotting. Recombinant proteins (10 µg) were applied to
4–20% gradient polyacrylamide gels (Bio-Rad) after heating them for 20 min at
95 °C in 2× Laemmli buffer with 2% β-mercaptoethanol (BME). SDS–PAGE was
performed at 200 V for 35 min following which the gels were stained with SimplyBlue Safe Stain (Thermo Fisher) to visualize the bands alongside a color prestained protein broad range standard (New England Biolabs). Deglycosylation was
carried out using the Protein Deglycosylation Mix II (New England Biolabs) as per
the manufacturer’s instructions.
Western blotting procedures to determine the proteolytic cleavage of the HA
were carried out as previously described24,33. HEK293T cells were co-transfected
with pCAGGS expression plasmids encoding for the corresponding HA and
pcDNA3.1 plasmids encoding human airway proteases (Genscript). The Western
blotting procedure was carried out with cell lysates, probing with either polyclonal
sera raised against the WSEIV HA in female BALB/c mice (at a dilution of 1:100)
or with a pool of anti-inﬂuenza B virus HA mAbs (at 10 µg/ml) characterized in
this ref. 33.
Hemagglutination assay. Recombinant HA starting at 10 µg diluted serially 2-fold
was incubated with 0.5% chicken or turkey erythrocyte suspension and incubated
at 4 °C for an hour. The plates were then scanned to determine the extent of
hemagglutination of these erythrocytes.
Glycan array. Glycan array binding analysis of the rHAs was carried out as
described here52,53. Brieﬂy, recombinant hexahistidine-tagged HA was precomplexed with a mouse anti-his Alexa 647 (antibody mouse anti-his 647 antibody, Abcam, ab237337, clone EPR20547) and goat-anti-mouse Alexa 647
antibodies (Thermo, Cat # A28181; RRID: AB_2536165). This was done in 50 µl
PBS-T (phosphate-buffered saline with 0.1% Tween-20) in a 4:2:1 molar ratio,
incubated for 15 min on ice, and the applied on the array for 90 min in a humidiﬁed chamber. Following multiple washes with PBS-T, PBS, and deionized water
the arrays were scanned to detect HA binding. Mean RFU and standard deviation
values were imported into Prism 7.0 and the corresponding graph was generated.
Bio-layer interferometry. As described previously, biolayer interferometry with an
Octet Red96 instrument (ForteBio) was used to determine the dissociation constant
of the HA-GM2 receptor interaction54. Recombinant hexahistidine-tagged HAs at
10 µg/ml was loaded onto Ni-NTA biosensors (Fortebio) for 780 s to ensure
saturation after a baseline step was established for 60 s. A second baseline was
established post-loading spanning 120 s. Then the association (300 s) and dissociation (900 s) kinetics were recorded as the HA-loaded sensors were dipped into
1.5-fold serially diluted concentrations of recombinant GM2 (Sigma Aldrich). The
reaction was carried out in a 1× kinetics buffer comprising of 1× PBS, 0.01% bovine
serum albumin (BSA) and 0.002% Tween 20. The dissociation constant was calculated accordingly using the suitable model for a biphasic association and dissociation proﬁle, and global curve ﬁt was applied to all the sensors. Octet Red96
Data Acquisition v12.0 software was used to acquire the biolayerinterferometry data.
Fusion assay. A polykaryon formation assay to determine the fusogenicity of the
WSEIV HA was performed as described in detail previously24. HeLa cells (CCL-2,
ATCC) were seeded in 96-well tissue culture plates (Corning) and transfected with
a pCAGGS plasmid expressing the WSEIV HA. The following day, the cells were
washed with Dulbecco’s phosphate buffer saline (DPBS), exposed to TPCK-treated
trypsin at 5 µg/ml for 15 min, washed with DPBS, and subsequently exposed to pH
adjusted DPBS ranging from pH 4.5 to 5.9 adjusted with citric acid. After 15 min of
an acid pulse, the cells were washed and allowed to recover and fuse in complete
DMEM for 4 h. The cells were then ﬁxed with 3.7% paraformaldehyde in PBS and
permeablized with 0.1% Triton X-100 for 15 min each. All of these steps were
performed at 33 °C. Staining was performed using the HCS Cell Mask Green (Life
Technologies) as per manufacturer’s instructions for 30 min at 5 µg/ml. Imaging
was performed using EVOS FL Cell Imaging microscope (Thermo Fisher) and the
images were collectively processed using Adobe Photoshop and annotated using
Adobe Illustrator.
ELLAs. ELLAs were performed as described in detail previously to determine the
enzymatic activity of the NAs or the NA inhibitor sensitivity of the NAs55. Brieﬂy,
Immulon 4 HBX plates (Thermo Scientiﬁc) were coated with 100 µl/well of fetuin
10

(Sigma) at 25 µg/ml overnight at 4 °C. The fetuin-coated plates were incubated with
2 fold dilutions of recombinant NAs starting at 10 µg/ml in 5% BSA in PBS
overnight at the indicated temperatures. The following day, the plates were washed
three times with PBS-T and were incubated with 5 µg/ml of peanut agglutinin
conjugated to horseradish peroxidase (PNA-HRP) for two hours at room temperature. The plates were washed with PBS-T three times and developed with
100 µl of Sigmafast o-phenylenediamine dihydrochloride (OPD) (Sigma Aldrich).
The only applied variation was that the overnight incubation was carried out at
four different temperatures (4, 20, 33, and 37 °C) to determine the temperaturedependent proﬁle of the NAs. When oseltamivir, zanamivir, and peramivir were
used, the starting concentration applied was 156.28 µM with 2-fold serial dilutions,
and they were pre-incubated with the recombinant NAs for 1 h shaking at 37 °C
after which the conventional ELLA protocol was followed. Substrate speciﬁcity
characterization and speciﬁc enzyme activity determination was performed in
ELLA assays identical to that described in ref. 26. Absorbance measurements were
carried out at 490 nm following the development with Sigmafast OPD, and the
speciﬁc enzyme activity (inverse of half-maximum lectin binding) was determined
following a non-linear regression analysis in Graphpad Prism 7, and was plotted
normalized to the fetuin-ECA to determine activity per amount of protein in
context of cleavage of α2,3 or α2,6-linked sialic acids.
Michaelis–Menten kinetics. Enzyme kinetics and the Michaelis–Menten parameters were determined as described previously32. Brieﬂy, recombinant NAs at a
ﬁxed concentration of 10 µg/ml were incubated with 1.5 fold dilutions of the
ﬂuorogenic MUNANA substrate in MES (2-ethanesulfonic acid2-ethanesulfonic
acid) buffer with suitable blank controls for background ﬂuorescence. The plates
were incubated at 37 °C and readings for relative ﬂuorescence units (RFUs) were
recorded at every 90 s for 40 min using a Gen5 v3.0 Software and a Synergy H1
Microplate Reader (BioTek). The RFU readings were captured at excitation and
emission wavelengths of 360 and 448 nM. Velocity of the reaction was determined
by plotting the RFU readings against time, and the Michaelis–Menten parameters
Vmax and Km were determined through non-linear regression ﬁts of the velocity
and MUNANA concentrations in Graphpad Prism 7.
Free sialic acid assay and thin layer chromatography. Recombinant GM2
(100 μM) was incubated with WSEIV NA or BSA at 10 μg/ml. As a positive control,
fetuin (100 μM) was incubated with WSEIV NA (10 μg/ml). The reactions were
then analyzed using a Sialic Acid (NANA) assay kit (Abcam) as per the manufacturer’s instructions. The amount of free sialic acid was determined by extrapolation from a standard curve and graphed using Graphpad Prism 7. The same
samples were also applied using a 700 series microliter syringe (Hamilton) onto
pre-scored silica gel TLC plates (Millipore Sigma) and placed in a running buffer of
ethanol:acetic acid:water at 5:2:1. As a control for both experiments, GM2 was also
incubated with BSA as an irrelevant protein. Assay buffer without GM2 was also
applied to the TLC plate as a blank control. The plates were visualized using a BioRad Gel Doc (Bio-Rad), and the chromatogram was annotated on Adobe
Illustrator.
ELISAs. ELISAs were performed as previously described in detail33. Immulon 4
HBX plates (Thermo Scientiﬁc) were coated overnight with 2 µg/ml of recombinant
protein in 1× coating buffer (Seracare). The plates were blocked with 3% milk
powder in PBS-T for one hour at room temperature following which they were
incubated with 3-fold dilutions of mAbs starting at 30 µg/ml or human serum
samples at a dilution of 1:250 for two hours at room temperature. The plates were
washed three times with PBS-T and stained with the appropriate goat anti-human
(Invitrogen, 31410) or goat anti-mouse HRP-tagged (Rockland, 610-1302) antibody at a dilution of 1:3000 in PBS-T and developed using Sigmafast OPD.
Information surrounding individual antibodies used in the primary staining procedure are available in the cited references.
Human serum samples. Serum samples were obtained from healthy participants
participating in a longitudinal, observation, non-interventional study (STUDY-1601199, PI: V. Simon) approved by the Institutional Review Board of the Mount
Sinai School of Medicine. Informed consent was obtained prior to study participation and participants provided written permission to biospecimen banking and
future research use. Samples were collected between 2017 and 2019. All samples
were de-identiﬁed and analyzed in a blinded manner.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.

Data availability
All data are available in the manuscript or the supplementary materials. Source data are
provided with this paper. HA (4FQM) and NA (4CPL) structures for B/Brisbane/60/2008
were obtained from PDB. Sequences for the HAs and NAs for the phylogenetic trees were
obtained from GISAID (H1-H18: H1-H18: EPI1349891, EPI899625, EPI673678,
EPI1007628, EPI942074, EPI1154383, EPI1090164, EPI1154159, EPI1103524,
EPI953583, EPI774886, EPI1007631, EPI967018, EPI750076, EPI965435, EPI939704,
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EPI356309, EPI486922; B/Lee/1940 HA: EPI243230; B/Phuket/3073/2013 HA:
EPI1799824; B/Colorado/06/2017 HA: EPI969380; N1-N11: EPI1381203, EPI899627,
EPI939823, EPI1154448, EPI1007658, EPI939830, EPI750078, EPI941550, EPI965439,
EPI356311, EPI356298; B/Lee/1940 NA: EPI366432; B/Phuket/3073/2013 NA:
EPI1799823; B/Colorado/06/2017 NA: EPI969379). WSEIV HA and NA (MG600041.1
and MG600042.1) and B/Malaysia/2506/2004 HA and NA (CY040449.1 and
CY040451.1) sequences were used for the pairwise alignment represented in
Fig. 1. Source data are provided with this paper.
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